This compound is an N-oxide derivative of alprazolam, characterized by a triazolobenzodiazepine core with a chlorine substituent and an N-oxide functional group. It is primarily identified as an active pharmaceutical ingredient impurity, relevant to quality control and impurity profiling in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Secobarbital sodium
pharmaceutical raw material
Flupentixol decanoate
pharmaceutical raw material
MIDODRINE HYDROCHLORIDE
pharmaceutical raw material
Doxifluridine
pharmaceutical raw material
8-chloro-1-methyl-5-oxido-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-5-ium
WHYAIKHHRCPZBI-UHFFFAOYSA-N
CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=[N+](C2)[O-])C4=CC=CC=C4
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.